1.

Harsono, Migren Dalam Buku Ajar Neurologi Klinis, Edisi I, Gadjah Mada

University Press, 1996, hal 289-299.

2. Chawla J. Migrain headache. May 2017 [Cited 2017 1 Aug]; available from :

http://emedicine.medscape.com/article/1142556-overview#a1

3. Silberstein SD. Migrain. July 2016 [Cited 2017 2 Aug]; available from;

http://www.merckmanuals.com/professional/neurologic-

disorders/headache/migrain

4. World Health Organization. Headache Disorders. 2016. [Cited 2017 5 Aug].

Available From : http://www.who.int/mediacentre/factsheets/fs277/en/

5. Headache Classification Subcommittee of the International Headache Society.

The International Classifi cation of Headache Disorders: 2nd edition.

Cephalalgia 2004;24 Suppl 1:1–160.

6. Neurobiology of migraine Daniela Pietrobon* and Jörg Striessnig‡

7. Mathew NT, Tfelt-Hansen P. General and Pharmacologic Approach to

Migraine management. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen

P, Welch KMA, eds. The Headaches, 3rd ed. Philadelphia, PA: Lippincott

Williams & Wilkins; 2006 p.433-440.

8. Chowdhury D. Acute Management of Migraine.JAPI 2010;58:21-25.

9. Bogdanov VB, Multon S, Chauvel V, Bogdanova OV, Makarchuk MY,

Schoenen J. Cortical spreading depression and associated neuronal Fos

expression in rats are aff ected diff erentially by chronic treatment with

lamotrigine, valproate or ribofl avin. Cephalalgia 2009;29(Suppl 1):10.

10. Dalkara T, Zervas NT, Moskovitz MA (2006) From spreading depression to

trigeminovascular system. Neurol Sci 27(Suppl 2):S86–S90

11. Blau JN. Migraine: theory of pathogenesis.lancet. 2010

12. Snow V, Weiss K, Wall EM, Mottur-Pilson C, American Academy of Family

Physicians, American College of Physicians–American Society of Internal

Medicine. Pharmacologic management of acute attacks of migraine and

prevention of migraine headache. Ann Intern Med 2002;137:840-9.

13. Schuurmans A, van Weel C. Pharmacologic treatment of migraine: Comparison

of guidelines. Can Fam Physician 2005;51:838-843.

14. Rapoport AM. Acute and prophylactic treatments for migraine: present and

future. Neurol Sci 2008;29:S110–S122.

15. Ross-Lee LM, Eadie MJ, Heazlewood V, Bochner F, Tyrer JH. Aspirin

pharmacokinetics in migraine. The eff ect of metoclopramide. Eur. J. Clin.

Pharmacol. 2005; 24: 777–85.

16. Bates D, Ashford E, Dawson R, et al. Subcutaneous sumatriptan during the

migraine aura. Sumatriptan Aura Study Group. Neurology. 1994; 44(9): 1587–

92.

17. MacGregor A. Acute migraine attacks. In: Candelise L, Hughes R, Liberati A,

Uitdehaag BMJ, Warlow C (Ed.). Evidence-based Neurology: Management of

Neurological Disorders. Blackwell Publishing. USA. 2007. Part 2: Chapter 5,

page 29-39.
18. Sandor PS, Di Clemente L, Coppola G et al., “Effi cacy of coenzyme Q10 in

migraine prophylaxis: a randomized controlled trial”, Neurology (2005);64: pp.

713–715.

19. Sun-Edelstein C, Mauskop A. Foods and Supplements in the Management of

Migraine Headaches. Clin J Pain 2009;25:446–452.

20. Hashizume M. Psychosomatic approach for chronic migraine. Rinsho

Shinkeigaku. 2011 Nov;51(11):1153-5.

21. McGrath PJ, Penzien D, Rains JC. Psychological and behavioral treatments of

migraines. In: Olesen J, Goadsby PJ, Ramadan NM, et al., editors. The

Headaches. 3rd ed. Philadelphia: Lippincott Williams and Wilkins. 2006. pp.

441–8.

22. Pryse-Phillips W E.M., Dodick DW, Edmeads JG, Gawel MJ, Nelson RF, Purdy

RA, et.al. Guidelines for the nonpharmacologic management of migraine in

clinical practice. CMAJ 2008 July;159(1):47-54.

23. Bakal DA. The Psychology of Chronic Headache. New York: Springer

Publishing Company, Inc. 2002.

24. Edvinsson L, Linde M. New drugs in migraine treatment and prophylaxis:

telcagepant and topiramate. Lancet 2010; 376:645–55.

25. Loder E, Biondi D. General Principles of Migraine Management: The Changing

Role of Prevention. Headache 2005;45[Suppl 1]:S33-S47.

26. Kaniecki R. Neuromodulators for Migraine Prevention. Headache 2008;48:586-

600.
27. Usai S, Grazzi L, Bussone G. Gingkolide B as migraine preventive treatment in

young age: results at 1-year follow-up. Neurol Sci 2011(32);Suppl 1:S197–

S199.

28. Pringsheim T, Davenport WJ, Becker WJ. Prophylaxis of migraine headache.

CMAJ 2010(4);182(7):E269-E276.